Versatope Therapeutics
Lowell
About Versatope Therapeutics
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. The company develops a bacterial factory nano particle technology and multiple epitopes can be displayed to overcome strain-specific immunity, enabling biotechnology companies to develop a single vaccine to protect against multiple strains of influenza.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.7M
- Last round: Grant (May 2025)
- Website: versatope.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/versatope-therapeutics-97314 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.